- Global Pharma News & Resources

12th World Congress on Dementia and Alzheimer Rehabilitation

Conference Title:  12th World Congress on Dementia and Alzheimer Rehabilitation

Short name: Dementia Meetings 2019

Date: April 11-12, 2019.

Venue: Stockholm, Sweden

Program Director: Edward Parker



Address: 47, Church field Road, London, W3 6AY

Phone no. - +44 2039363178


Dementia 2019, Dementia Conference , Alzheimer’s  Conference, Dementia Conferences, Alzheimer’s Conferences, Vascular Dementia Conferences, Dementia Conferences 2019 , Mental Health conferences, Sweden Psychiatric Conferences, Dementia and Alzheimer conferences 2019, Dementia and Alzheimer conferences, Stockholm psychology conference, Sweden psychology conferences, Alzheimer Rehabilitation conference, Dementia Rehabilitation, Dementia 2019 conference, Europe Dementia conference, Dementia  Conference Sweden

Meta keywords:              

Alzheimer Rehabilitation, Alzheimer disease, Dementia care, Neurology disorder, Dementia Conference, Dementia Conferences, Alzheimer Conference, Alzheimer’s Conferences, Alzheimer Rehabilitation conference, Dementia Rehabilitation,  Dementia 2019, Dementia 2019 conference, Europe Dementia conference,  Neurology Conferences, Dementia Events, Dementia Congress, Dementia meeting, Alzheimer’s meeting, vascular dementia conferences, Dementia care 2019 , Dementia  Conference Sweden, Mental disorder, Dementia and Alzheimer conference, , Dementia and Alzheimer conferences, Dementia and Alzheimer conference 2019

Meta description:

European dementia 2019 Conference, The world’s largest Dementia and Alzheimer Rehabilitation Conference, Join the Dementia and  Alzheimer Rehabilitation at April 11-12, 2019 Stockholm, Sweden. Meet leading psychiatry Doctors, Physicians, Researchers, psychiatrist and students from Croatia, Zagreb, Austria, Denmark, Finland, Croatia, Germany, Italy, Netherlands, Norway, Poland, Spain, Switzerland, Turkey and all over the world to the conference on :  12th World Congress on Dementia and Alzheimer Rehabilitation.

Conference URL :

Abstract url:

Registration url:


It is with great pleasure we, Dementia 2019 would like to express by personal gratitude to invite you to the “12th World Congress on Dementia and Alzheimer Rehabilitation” scheduled during April 11-12, 2019 Stockholm, Sweden.

Dementia Meetings 2019 anticipates more than 500 participants around the globe to experience thought provoking Keynote lectures, oral, video & poster presentations. This year Dementia conference will offer ample opportunities for all stakeholders working on Dementia and Alzheimer and its rehabilitation to expose their research work.

Within this splendid setting, we plan to deliver a conference that will exceed your expectations. Our Dementia conference aims to make people with dementia feel safe and to create a familiar environment for them.

The Conference will be organized around the theme “Innovative Approaches to Support: Dementia & Alzheimer Rehabilitation”.

This year in Dementia 2019 conference, we hope that you will seize the opportunity to rekindle on-going connections and spark new ones with your colleagues from around the globe.


Track 1: Dementia

Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer’s disease, vascular dementia, which occurs after a stroke, is the second most common dementia type.

Track 1-1Dementia with Lewy Bodies

Track 1-2mixed dementias

Track 1-3Front temporal dementias

Track 1-4Normal pressure hydrocephalus

Track 1-5Signs and symptoms of dementia

Track 1-6Risk factors of cognitive decline

Track 2: Alzheimer’s Disease

Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80% of dementia cases. Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80% of dementia cases. Alzheimer's is not a normal part of aging.

Track2-1Risk Factors of Alzheimer’s

Track2-2Diagnosis of Alzheimer’s

Track2-3Treatments of Alzheimer’s

Track2-4Clinical Studies of Alzheimer’s

Track2-5Alzheimer’s disease Pathophysiology and Disease Mechanisms

Track 3: Dementia and Aging

Aging: Not being able to remember details of a conversation or event that took place a year ago, Not being able to remember the name of an acquaintance, Forgetting things and events occasionally, Occasionally have difficulty finding words, You are worried about your memory but your relatives are not..


Dementia: Not being able to recall details of recent events or conversations, Not recognizing or knowing the names of family members, Forgetting things or events more frequently, Frequent pauses and substitutions when finding words, Your relatives are worried about your memory, but you are not aware of any problems.

Track 3-1Neuro-anatomical changes in ageing

Track 3-2Granulovacuolar degeneration

Track 3-3Advances of research in ageing and dementia

Track 4: Vascular Dementia

Vascular dementia occurs when vessels that supply blood to the brain become blocked or narrowed. Strokes take place when the supply of blood carrying oxygen to the brain is suddenly cut off. However, not all people with stroke will develop vascular dementia.

Track 4-1vascular dementia prognosis

Track 4-2Young onset dementia

Track 4-3Multi-infarct dementia

Track 4-4mixed dementia

Track 4-5Parkinson dementias

Track 4-6Advances in vascular dementia therapy

Track 5: Geriatrics Dementia and Cognitive Disorders

Geriatrics or geriatric medication may be a specialty that focuses on health care of older people. It aims to push health by preventing and treating diseases and disabilities in older adults. There’s no set age at that patients are also underneath the care of a specialist or geriatric.

Track 5-1Delirium

Track 5-2Mild and Major Neurocognitive Disorder

Track 5-3cognitive impairment

Track 6: Animal Models in Dementia

The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.

Track 6-1Neurobehavioral Toxicology Testing

Track 6-2Pre-clinical testing and clinical translation

Track 6-3Protein-protein interactions

Track 6-4Genetics of translational models

Track 6-5Animal models of human cognitive aging

Track 7: Amyloid Protein in Alzheimer’s and Dementia

Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyper phosphorylated and cleaved forms of the microtubule-associated protein tau.

Track 7-1Amyloid Imaging

Track 7-2FDG-PET

Track 7-3Amyloid Immunotherapy

Track 8: Amyloid Imaging in Dementia

The AIT(Amyloid Imaging Task Force) concluded that amyloid imaging could potentially be helpful in the diagnosis of people with cognitive impairment when considered along with other clinical information, and when performed according to standardized protocols by trained staff.

Track 9: Neurodegenerative Diseases

Degenerative nerve diseases affect many of your body's activities, such as balance, movement, talking, breathing, and heart function. Sometimes the cause is a medical condition such as alcoholism, a tumour, or a stroke. Other causes may include toxins, chemicals, and viruses. Sometimes the cause is not known.

Track 9-1Brain diseases

Track 9-2Traumatic brain injury

Track 9-3Amyotrophic lateral sclerosis

Track 9-4Spinal muscular atrophy

Track 9-5Migraine

Track 9-6Stroke

Track 10:  Parkinson’s disease with Dementia

Parkinson's disease (PD) is a type of movement disorder. It happens when nerve cells in the brain don't produce enough of a brain chemical called dopamine. Sometimes it is genetic, but most cases do not seem to run in families. Exposure to chemicals in the environment might play a role. Parkinson’s disease usually begins around age 60, but it can start earlier. It is more common in men than in women.

Track 10-1Huntington’s Disease

Track 10-2Anxiety

Track 10-3Muffled speech

Track 11: Dementia Care Management

The developing number of vascular dementia patients prompts both approach, monetary and wellbeing association imperatives. Numerous social insurance frameworks have created case administration programs with a specific end goal to advance dementia patients and guardians care and administrations conveyance.

Track 11-1Advances in dementia care management

Track 11-2Dementia care management program

Track 11-3Undernutrition and obesity in dementia

Track 11-4Advance care planning

Track 12: Dementia Nursing

People with vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects apraxia, agonise, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities.

Track 12-1Dementia nursing care plan

Track 12-2Music therapy in dementia

Track 12-3Physiotherapy for dementia

Track 12-4Clinical features of dementia

Track 12-5Therapeutic interventions in dementia

Track 13: Neuropharmacology

Neuropharmacology is an extremely wide locale of science that includes numerous parts of the sensory system from single neuron control to whole ranges of the cerebrum, spinal line, and fringe nerves. To better comprehend the premise behind medication advancement, one should first see how neurons speak with each other.

Track 13-1Neuroscience and neuropharmacology

Track 13-2Neurochemical interaction

Track 13-3Molecular neuropharmacology

Track 13-4Behavioral neuropharmacology

Track 13-5Advance research in neuropharmacology

Track 14: Recent Advancement in Treatments of Dementia

Currently, there is no cure for Alzheimer's. But drug and non-drug treatments may help with both cognitive and behavioural symptoms. Researchers are looking for new treatments to alter the course of the disease and improve the quality of life for people with dementia.

Track 14-1Medications for Memory Loss

Track 14-2Amyloid Immunotherapy

Track 14-3Clinical Trials

Track 15: Treating Dementia

Early discovery and exact analysis are critical, as vascular dementia is at any rate halfway preventable .Ischemic changes in the cerebrum are irreversible, however the patient with vascular dementia can exhibit times of solidness or even gentle change. Since stroke is a basic piece of vascular dementia, the objective is to forestall new strokes. This is endeavoured through decrease of stroke chance components, for example, hypertension, high blood lipid levels, atrial fibrillation, or diabetes mellitus.

Track 15-1Primary mental health care and nursing

Track 15-22Psychopharmacological treatment

Track 15-3Advanced drugs for dementia

Track 15-4Cognitive behavioural therapy

Track 15-5Family therapy in nursing

Track 16: Dementia Rehabilitation and Therapy

Novel therapeutics is a standout amongst the most energizing uses of data preparing frameworks is in diagnostics and treatment. This is not astonishing, given that illness analysis is in its center a data handling undertaking that finishes with a choice. In numerous infections, the conclusion can be performed in singular cells.

We are used to thinking of rehabilitation in terms of physical rehabilitation following injury, but it is equally relevant for people with cognitive, rather than physical, impairments. This includes people whose impairments result from long-term, progressive neurodegenerative conditions. In cognitive rehabilitation, these principles are applied to enable people with dementia to maintain or optimize functioning.

Track 16-1Novel therapeutics strategies for dementia

Track 16-2Novel therapeutics molecule

Track 16-3Anti-dementia drugs

Track 16-4Novel drug target for the treatment of dementia

Why to attend?

12th World Congress on Dementia and Rehabilitation is organizing an outstanding Scientific Exhibition/Program and anticipates the world's leading Neurologists, health professionals involved in the profession and practice of neuroscience. The event will also reflect interest of specialists in the clinical research on dementia and Alzheimer’s disease. Conference series organizing this international event for people to take part and gain a better understanding of such diseases, to access treatment as well as information, advice and support and to have their health monitored more closely.

This International meeting is an effort to make possible interactions among world leading scientists, research scholars, professionals, young researchers from different parts of the world to exchange their knowledge and conduct symposia, show experiments with new innovative techniques that disseminate information about clinical tradition, best practices, skills and knowledge in the field of neuroscience. In Dementia and Rehabilitation 2018, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Dementia and Neurology.

Target Audience:

Neurologists and Directors





Health care professionals


Industrial Experts



Nutritional Scientists

Lecturers and Students from Academia in the study of Dementia

Students from Academia in the research of Neurology

Neuro Physiotherapists


Access to all Sessions

Handbook & Conference Kit

CPD Certification

Abstracts will be published with DOI number

Certificate Accreditation by the International Organizing Committee

Abstracts will be published in the conference souvenir and respective international journals

Ask the Expert Forums (One to One Pre-Scheduled meeting on interest and availability)

Access to the attendees' email list (post conference)

25% abatement on the registration fees for the next annual conference

Coffee break (Refreshments and snacks) Lunch during the conference

Free Wi-Fi

Learning Objectives


  1. Share and describe new developments in the field of Forensic Psychology & Criminology
  2. They can compare research guidelines and good practices with new current practices and strength or gaps
  3. Discover new research techniques in development with practical implication used in recovery treatment or research fields
  4. Participants can build their networks of professionals and can find valuable resources
  5. Explain recent or upcoming changes in policy to identify provider involvement areas
  6. Demonstrate the knowledge while treating patients with psychological disorders in clinical aspects
  7. Usage of various patient screening tools that used to identify usage of substance abuse and interpretation results
  8. Enhance patient’s readiness to change in their risky behaviours by using motivational interviewing
  9. Also, will be offer referral in regards to behavioural interventions which include support groups as well as mutual groups that will assist in recovery process

Scientific Program:

Welcome Ceremony

Keynote Presentation

Presentation over concurrent streams

Half day Workshop

Poster Presentation

Video/ Virtual Presentation

Exhibitor and Sponsor displays

Symposium and Networking

Best Poster Award

Young Researcher Award

Why Sweden

Stockholm is the capital of Sweden. The first part of the name “stock” means “log” in Swedish and “fortification” in Greek and second part of the name “holm” means “islet” though Stockholm is often known as “World’s Biggest Small Town”. Stockholm lies on a number of islands and peninsulas. The city centre is nearly situated on the water. Stockholm is one of the cleanest capitals in the world. This city was Europe's first “green capital”. The city became the venue for the award of the first noble prizes in the year 1901. The city’s subway is also known as the world’s longest art gallery with the majority of its stations being decorated with paintings, sculptures and mosaics. The first ice hotel of the world was built near the village of Jukkasjärvi, Sweden.

Area-188 sq km (city proper)

Area Code-08

Currency-Kronor (kr)


Stockholm has always been a dynamic city, from its first days as a trading hub to its current incarnation as a major European biotechnology region and a centre of food and fashion.

International SUPPORTED Journals:

Journal of Alzheimer’s Disease & Parkinsonism

Journal of Neurological Disorders

Brain Disorders & Therapy


12th World Congress on Dementia and Alzheimer Rehabilitation

Editor Details

Related Links

Last Updated: 19-Nov-2018